YOLFTbeta
Botanix Pharmaceuticals Ltd

Botanix Pharmaceuticals Ltd

BOT · AU · Healthcare / Biotechnology

0.009AUD-0.00 (-10.00%)

Price History

Full chart

Market Stats

Previous Close0.01
Open0.01
Day Range0.009 – 0.01
52-Week Range0.017 – 0.17
Volume947.25K
Market Cap49.71M
P/E (TTM)0.00
Forward P/E5.84
EPS-0.03
Dividend Yield0.00%
Beta0.86
50-Day Avg0.0201
200-Day Avg0.0478

About

Botanix Pharmaceuticals Limited, a pharmaceutical company, engages in the research and commercialization of solutions for skin diseases and infections in Australia and the United States. The company's lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used to treat underarm sweating in adults and children 9 years of age and older. It also develops BTX 1503, a transdermal gel formulation, which is in Phase 3 clinical trial for the treatment of serious acne in adults and teenagers; BTX 1702 that is in Phase 1b/2 clinical trial to treat papulopustular rosacea; BTX 1204A for treating atopic dermatitis; and BTX 1801, which has been completed Phase 2a clinical trial for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus. The company was incorporated in 1984 and is based in Melbourne, Australia.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Howie McKibbon
  • Employees0
  • HeadquartersTower 5, Collins Square, Melbourne, VIC, Australia, 3008, Australia
  • Websitehttps://www.botanixpharma.com

Leadership

  • Mr. Vincent P. IppolitoExecutive Chairman · b. 1959
  • Dr. Howie McKibbonChief Executive Officer
  • Mr. Graeme MorisseyChief Financial Officer
  • Mr. Chris LesovitzChief Financial Officer of United States of America
  • Mr. Paul SeabackChief Operating Officer
  • Dr. Boris Meyerson Ph.D.Chief Business Officer
  • Mr. David MorganHead of Corporate Affairs
  • Mr. Andrew BickleyCompany Secretary
  • Mr. Darin Van ArsdaleDirector of Sales Operations

Financials

Income Statement

Currency: AUD1989-06-301990-06-301991-06-301992-06-301993-06-301994-06-301995-06-301996-06-301997-06-301998-06-301999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue19.00M21.00M25.52M26.82M33.08M45.03M66.64M41.33M40.53M--9.14M519.00K369.38K925.37K457.50K86493.00K51.00K35.00K9.00K1.00K----43.09K046.50K1.78M4.69M7.57M6.89M2.75M914.97K601.82K5.79M34.51M
Growth (%)-+10.53%+21.50%+5.13%+23.34%+36.10%+48.01%-37.99%-1.94%----94.32%-28.83%+150.52%-50.56%-99.81%+10663.89%-45.16%-31.37%-74.29%-88.89%------100.00%-+3723.66%+163.55%+61.63%-9.07%-60.00%-66.79%-34.23%+861.95%+496.16%
Cost of Revenue---------------885.50K-----------03.65M11.04M1.58K102.28K6.57M10.29M3.96M7.15M3.77M93.95M
Gross Profit19.00M21.00M25.52M26.82M33.08M45.03M66.64M41.33M40.53M----369.38K925.37K-427.99K864----------0-3.65M-9.26M4.68M7.47M315.80K-7.54M-3.05M-6.12M2.02M-59.43M
Gross Margin100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%----100.00%100.00%-93.55%100.00%------------7851.61%-521.03%99.96%98.65%4.59%-273.60%-332.91%-1016.72%34.85%-172.20%
Operating Expense2.84M2.91M3.05M3.88M5.12M6.40M7.58M12.63M0----994.38K2.42M547.01K3.69M----------291.00K4.72M12.88M26.53M36.97M10.58M8.40M9.75M9.61M82.81M9.88M
Operating Income16.16M18.09M22.47M22.95M27.96M38.63M59.06M28.69M40.53M-16.41M-7.89M-3.41M-441.99K-625.00K-1.50M-975.00K-3.69M-3.17M-3.72M-3.17M-3.14M-1.99M-1.52M-1.49M-1.66M-2.27M-453.00K-291.00K-8.38M-22.14M-21.84M-29.50M-10.27M-15.94M-12.80M-15.73M-80.79M-69.31M
Operating Margin85.06%86.15%88.06%85.55%84.52%85.80%88.62%69.43%100.00%---37.34%-85.16%-169.20%-161.99%-213.11%-427546.30%-3405.38%-7288.24%-9062.86%-34877.78%-198900.00%-----1051.29%--18012.90%-1245.33%-466.18%-389.50%-149.08%-578.62%-1398.49%-2614.12%-1395.62%-200.82%
EBITDA1.82M806.00K2.54M-991.00K3.11M7.22M10.10M5.17M-14.40M-16.41M-7.89M-3.41M-441.99K-389.00K-983.00K-713.35K23.63M-3.18M-3.71M-3.17M-3.15M-3.94M-1.52M-1.49M-1.82M-1.23M-526.00K-1.71M-4.77M-11.01M-17.16M-24.14M-10.06M-15.74M-12.63M-15.25M-80.65M-69.31M
EBITDA Margin9.59%3.84%9.96%-3.69%9.40%16.04%15.15%12.51%-35.53%---37.34%-85.16%-105.31%-106.23%-155.92%2735416.67%-3418.28%-7274.51%-9045.71%-35033.33%-394100.00%-----1220.70%--10258.06%-619.18%-366.15%-318.74%-146.09%-571.51%-1380.50%-2534.66%-1393.13%-200.82%
Net Income-72.00K-89.00K-61.00K--899.00K-1.43M-234.00K-132.00K85.00K-85.00K-3.17M-353.02K-1.41M-1.40M-958.59K2.10K-2.78M-3.42M-2.83M-3.04M-1.99M-1.52M-1.57M-1.85M-1.13M-1.01M-1.71M-4.77M-11.01M-17.04M-16.73M-3.33M-13.17M-9.15M-13.87M-86.40M-69.77M
Net Income Margin-0.38%-0.42%-0.24%--2.72%-3.17%-0.35%-0.33%---34.69%-68.02%-381.72%-151.18%-209.52%242.82%-2991.40%-6700.00%-8071.43%-33811.11%-198900.00%-----2355.53%--10264.52%-619.35%-363.62%-220.90%-48.41%-478.08%-1000.47%-2304.68%-1492.37%-202.15%
R&D----------------2.28M1.87M2.50M1.86M2.03M1.18M889.36K952.19K1.13M966.35K-16.63M3.65M11.04M16.63M13.70M6.57M10.29M5.73M1.81M143.95K-
R&D as % of Total Revenue----------------264351.85%2011.83%4896.08%5302.86%22577.78%117500.00%------7851.61%620.98%354.89%180.87%95.41%373.61%625.92%301.25%2.49%-
Interest Expense374.00K873.00K593.00K610.00K672.00K692.00K652.00K84.00K140.00K160.00K32.00K61.00K0000000000077.47K24.80K1.32K1.03K4843.23K2.50K11.21K50.98K55.94K37.44K81.74K10.66K5.37M2.84M
Interest Expense % of Total Revenue1.97%4.16%2.32%2.27%2.03%1.54%0.98%0.20%0.35%--0.67%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%----2.38%-6.94%0.14%0.24%0.67%0.81%1.36%8.93%1.77%92.70%8.22%

Balance Sheet

Currency: AUD1989-06-301990-06-301991-06-301992-06-301993-06-301994-06-301995-06-301996-06-301997-06-301998-06-301999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets24.06M25.58M27.41M25.92M38.03M48.56M68.16M57.05M50.26M30.36M16.15M5.27M5.86M4.51M2.94M2.43M3.68M2.51M3.50M2.37M2.02M58.59K42.55K17.86K8.16K2.55M1.32M3.70M5.91M17.71M5.20M25.31M21.95M14.04M24.84M112.46M129.10M105.98M
Total Liabilities11.82M13.62M14.54M14.52M19.68M22.52M29.72M19.13M18.22M14.61M8.06M118.00K169.34K457.88K289.29K181.62K223.25K283.89K603.47K1.08M1.14M1.86M2.27M2.35M2.51M309.85K91.58K515.83K470.60K1.43M4.58M1.67M1.15M5.89M1.88M3.73M47.80M42.45M
Total Equity11.98M11.66M12.56M11.41M12.88M19.58M37.09M37.91M32.05M15.84M8.08M5.15M5.69M4.05M2.65M2.24M3.43M2.22M2.90M1.29M877.74K-1.80M-2.23M-2.33M-2.50M2.24M1.23M3.18M5.44M16.28M615.22K23.64M20.80M8.15M22.95M108.73M81.30M63.52M
Cash399.00K185.00K718.00K446.00K2.08M4.22M5.31M4.55M3.90M4.57M1.60M4.39M5.83M2.96M878.00K1.31M1.68M511.79K1.48M373.07K9.66K33.21K7.37K10.48K1.47K2.51M1.31M3.65M5.72M17.26M4.70M24.65M21.55M7.29M10.25M79.31M64.97M36.63M
Total Debt5.54M5.59M5.73M6.06M6.33M7.03M4.43M1.65M822.00K391.00K956.00K-----1.10K-----310.98K477.44K428.18K-----420.62K420.63K259.32K122.41K--32.51M14.74M
Net Debt5.14M5.40M5.01M5.61M4.26M2.80M-879.00K-2.90M-3.08M-4.18M-649.00K-4.39M-5.83M-2.96M-878.00K-1.31M-1.68M-511.79K-1.48M-373.07K-9.66K-33.21K303.61K466.96K426.71K-2.51M-1.31M-3.65M-5.72M-17.26M-4.70M-24.22M-21.30M-7.16M-10.25M-79.31M-32.45M-21.89M

Cash Flow

Currency: AUD1989-06-301990-06-301991-06-301992-06-301993-06-301994-06-301995-06-301996-06-301997-06-301998-06-301999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow--1.93M1.45M1.41M2.51M6.24M46.00K-3.29M7.23M-4.41M-1.54M-332.70K-1.17M--589.68K-2.84M-3.01M-2.75M-2.38M-1.62M-861.12K-692.97K-1.12M-1.04M-1.29M-1.20M-6.69K-4.64M-9.91M-13.14M-17.36M-2.97M-11.18M-12.07M-8.13M-78.58M-64.60M
Investing Cash Flow---1.17M-1.70M-5.61M-4.67M-7.42M-5.08M-1.40M-1.54M951.00K4.99M870.00K-1.45M-1.20M464.00K889.00K-18.89K-2.61K-1.00K-------404.03K-13.29K-13.29K-13.29K-151.19K-8.28K-2.92M-7.05M-18.00M-1.05M-408.96K
Financing Cash Flow--895.00K367.00K6.69M3.88M2.81M3.85M2.33M-2.57M503.00K-126.00K898.00K-237.00K-554.00K2.41M1.58M4.01M1.27M1.26M884.67K667.13K1.12M1.03M3.80M-3.25M6.71M21.45M568.65K37.31M-125.50K-152.41K22.03M95.10M65.36M36.58M
Capital Expenditure001.46M1.93M5.13M5.68M9.24M6.31M4.31M2.15M394.00K895.00K0256.00K1.20M280.00K11.00K18.89K2.61K1.00K000000013.29K13.29K13.29K13.29K90.05K8.28K2.92M7.05M18.00M286.43K3
Free Cash Flow--474.00K-479.00K-3.72M-3.17M-3.00M-6.26M-7.60M5.08M-4.80M-2.43M-332.70K-1.43M-1.20M-869.68K-2.86M-3.03M-2.75M-2.38M-1.62M-861.12K-692.97K-1.12M-1.04M-1.29M-1.20M-6.69K-4.64M-9.91M-13.15M-17.45M-2.98M-14.11M-19.13M-26.13M-78.87M-64.60M
Dividends Paid-----852.00K1.67M2.55M1.37M----------------589.62K-06.15M--34.15M-20.30M1.32M---
FCF to OCF--24.53%-33.10%-263.62%-126.23%-48.01%-13619.57%231.02%70.29%108.93%158.18%100.00%121.83%-147.48%100.39%100.63%100.09%100.04%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.10%100.52%100.28%126.13%158.42%321.47%100.36%100.00%
Dividend Paid to FCF------26.90%-55.56%-40.72%-18.09%-----------------45.69%-0.00%-132.45%---195.71%--143.93%-6.88%---

Earnings

Report DateFeb 19, 2016Aug 31, 2016Feb 28, 2017Sep 21, 2017Feb 26, 2018Aug 30, 2018Feb 28, 2019Aug 19, 2019Feb 27, 2020Aug 31, 2020Feb 26, 2021Aug 30, 2021Feb 24, 2022Aug 31, 2022Feb 28, 2023Feb 25, 2025May 28, 2025Aug 29, 2025Dec 3, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.00--0.000.000.000.000.00
EPS Actual0.000.000.00-0.010.00-0.02-0.01-0.02-0.01-0.010.000.00-0.01-0.010.00-0.020.00-0.030.00
Surprise-------------------
Timing-------------Pre-marketAfter-hours----

Key Statistics & Ratios

Market Cap49.71M
Enterprise Value41.13M
Trailing P/E0.00
Forward P/E5.84
Price / Sales1.47
Price / Book0.82
EPS-0.03
Book Value0.023
Revenue (TTM)33.80M
Gross Profit (TTM)19.45M
EBITDA-66.99M
Profit Margin-206.41%
Operating Margin-206.36%
Return on Equity-96.35%
Return on Assets-36.86%
Shares Outstanding2.76B
Shares Float2.44B
Beta0.86
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

19962×
52.50Oct 3, 199670.00Mar 21, 1996
19952×
60.00Sep 20, 19959.00Mar 24, 1995
19942×
37.19Sep 22, 199449.58Feb 18, 1994

Stock Splits

  • Jun 16, 20161:3
  • Jan 23, 20141:50
  • Aug 23, 20041:4
  • Jul 31, 20011:3
  • Nov 15, 19941.0043:1